VR Adviser’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
VR Adviser's ADRX Position: Q3 2026 in Review
VR Adviser opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 1,625,793 shares worth $32.4M. The stake represents 1.58% of the portfolio and ranks #18 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- VR Adviser held 1,625,793 shares of ADARx Pharmaceuticals worth $32.4M as of Q3 2026.
- ADARx Pharmaceuticals was a new VR Adviser position in Q3 2026.
- ADARx Pharmaceuticals made up 1.58% of VR Adviser's portfolio in Q3 2026, its #18 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on VR Adviser's 13F filing for Q3 2026, filed 16 Nov 2026.